Stocks of the Hour: Immutep, Altech Batteries, Cygnus Metals
To register for Friday’s webinar click here. Immutep Limited (ASX:IMM) has fully recruited participants for Part A of its Phase I study evaluating IMP761, a novel LAG-3 immunotherapy. The single-dose, placebo-controlled trial has been completed without any safety issues following drug administration. Shares are trading 2.46 per cent higher at 31.25 cents. Altech Batteries Limited […]
Stocks of the Hour: Immutep, Altech Batteries, Cygnus Metals Read More »